Enliven Therapeutics, Inc. - Common Stock (NQ:ELVN)
Price and Volume
Detailed Quote| Volume | 237,940 |
| Open | 16.71 |
| Bid (Size) | 16.33 (200) |
| Ask (Size) | 16.38 (300) |
| Prev. Close | 16.73 |
| Today's Range | 15.88 - 16.71 |
| 52wk Range | 13.30 - 25.37 |
| Shares Outstanding | 41,151,111 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
12 Health Care Stocks Moving In Monday's Intraday Session ↗
November 03, 2025
What's going on in today's pre-market session ↗
August 15, 2025
Enliven Posts Loss Beat and Cash Surge ↗
August 13, 2025
Wall Street Mixed As Tech Stocks Fall, Fed Meeting Begins ↗
March 19, 2024
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
March 19, 2024
Frequently Asked Questions
Is Enliven Therapeutics, Inc. - Common Stock publicly traded?
Yes, Enliven Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Enliven Therapeutics, Inc. - Common Stock trade on?
Enliven Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Enliven Therapeutics, Inc. - Common Stock?
The ticker symbol for Enliven Therapeutics, Inc. - Common Stock is ELVN on the Nasdaq Stock Market
What is the current price of Enliven Therapeutics, Inc. - Common Stock?
The current price of Enliven Therapeutics, Inc. - Common Stock is 16.34
When was Enliven Therapeutics, Inc. - Common Stock last traded?
The last trade of Enliven Therapeutics, Inc. - Common Stock was at 12/26/25 01:44 PM ET
What is the market capitalization of Enliven Therapeutics, Inc. - Common Stock?
The market capitalization of Enliven Therapeutics, Inc. - Common Stock is 672.41M
How many shares of Enliven Therapeutics, Inc. - Common Stock are outstanding?
Enliven Therapeutics, Inc. - Common Stock has 672M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.